Targeting NDA submission for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 through accelerated approval pathway; on track to initiate APOLLO post-marketing confirmatory trial by mid-2025 Positive update from Phase 1b trial of DISC-0974 in patients with anemia of myelofibrosis (MF) presented at ASH 2024; initial data from ongoing Phase 2 expected in H2 2025
NORTHVILLE, Mich., Feb. 13, 2025 /PRNewswire/ — Cooper-Standard Holdings Inc. (NYSE: CPS) today reported results for the fourth quarter and full year 2024. Fourth Quarter 2024 Summary Sales totaled $660.8 million, a decrease of 1.9% vs. the fourth quarter 2023 Operating income totaled $31.7 million, an increase of $36.2 million vs. the fourth quarter of
Increases net subscriber-add expectations for 2025 significantly to 180-200,000, expecting to reach 2.6 million subscribers by year-end; Increases dividend policy by 25% to $10 million per quarter; AZOUR, Israel, Feb. 26, 2025 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN) today announced its consolidated financial results for the fourth quarter 2024. Highlights of Full
PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 (“Full Year 2024”) and three months ended December 31, 2024 (“Fourth Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the full year
TORONTO, Feb. 25, 2025 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) announced today its financial results for the three months and year ended December 31, 2024 (“Q4 2024”). Q4 2024 Highlights1 Significant transaction volume drives portfolio growth: Net mortgage investment portfolio increased by $72.2 million to $1,089.8 million in Q4 2024 as a result
LIVONIA, Mich., Feb. 21, 2025 (GLOBE NEWSWIRE) — Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or “the Company”), a leading provider of premium material handling, construction and environmental processing equipment and related services, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, after the
BEIJING, Feb. 18, 2025 /PRNewswire/ — Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with a strong Internet foundation, today announced its unaudited financial results for the quarter and fiscal year ended December 31, 2024. “2024 marked a pivotal year in our
– Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia in U.S., European Union, Kingdom of Saudi Arabia and United Arab Emirates; PDUFA Goal Date of September 7, 2025 – – Completed Enrollment for Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease; Topline Results Expected in Late 2025, with
– Loan Originations of $5.0 Billion for 2024, including $1.3 Billion for Fourth Quarter – – Net Income of $12.7 Million for 2024, including $2.8 Million for Fourth Quarter – – Diluted Earnings Per Share of $0.93 for 2024, including $0.20 for Fourth Quarter – MURRAY, Utah, Jan. 30, 2025 (GLOBE NEWSWIRE) — FinWise Bancorp
HOUSTON and TUPELO, Miss., Jan. 22, 2025 /PRNewswire/ — Cadence Bank (NYSE: CADE) (the Company), today announced financial results for the quarter and year ended December 31, 2024. Annual highlights for 2024 included: Achieved net income available to common shareholders of $514.1 million, or $2.77 per diluted common share, and adjusted net income from continuing